9265
繝、繝槭す繧ソ繝倥Ν繧ケ繧ア繧「繝帙�シ繝ォ繝�繧」繝ウ繧ー繧ケ譬ェ蠑丈シ夂、セ
ヤマシタヘルスケアホールディングス株式会社Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, outsources, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, lithotripsy, and stents. It also provides consulting services related to the construction of nursing care facilities, M&A, and support to medical and nursing care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reservations, posting agency for customer satisfaction surveys, and network security systems sales. In addition, the company offers network integration and software design and development; equipment used in physical therapy and rehabilitation, as well as related consumables such as surgical gowns, gloves, and bandages; manufactures and sells medical devices, and conduct contract research on medical ultrasound, as well as the development, sales, and consulting of medical devices and peripheral devices that use ultrasound. Yamashita Health Care Holdings,Inc. was founded in 1926 and is based in Fukuoka City, Japan.
Price
¥3,065
Market Cap
¥7.6B
Ent. Value
—
Net Cash
est
—
Shares Out.
2.5M
P / E
12.3×
EV / EBIT
—
P / Book
0.84×
P / NCAV
2.36×
Div. Yield
2.45%
Financials
| Metric |
FY 2025
EDINET ↗ |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥64.5B | ¥61.6B | ¥58.2B | ¥55.1B | ¥70.1B |
| Cost of Sales | ¥55.7B | ¥53.1B | ¥50.1B | ¥47.4B | ¥62.6B |
| Gross Profit | ¥8.8B | ¥8.5B | ¥8.0B | ¥7.7B | ¥7.5B |
| SG&A | ¥7.9B | ¥7.5B | ¥6.9B | ¥6.8B | ¥6.5B |
| Operating Income | ¥838M | ¥967M | ¥1.2B | ¥931M | ¥969M |
| Non-Operating Income | ¥96M | ¥79M | ¥71M | ¥86M | ¥73M |
| Dividend Income | — | — | — | ¥8M | ¥6M |
| Interest Income | — | — | — | ¥2M | ¥2M |
| Non-Operating Expenses | ¥25M | ¥26M | ¥20M | ¥13M | ¥15M |
| Interest Expense | ¥6M | ¥0M | ¥2M | ¥4M | ¥4M |
| Ordinary Income | ¥909M | ¥1.0B | ¥1.2B | ¥1.0B | ¥1.0B |
| Pre-tax Income | ¥943M | ¥871M | ¥635M | ¥1.0B | ¥1.1B |
| Income Taxes | ¥329M | ¥293M | ¥423M | ¥330M | ¥373M |
| Current Tax | ¥379M | ¥378M | ¥442M | ¥285M | ¥358M |
| Deferred Tax | ¥-49M | ¥-84M | ¥-18M | ¥45M | ¥15M |
| Net Income (owners) | ¥616M | ¥580M | ¥219M | ¥696M | ¥678M |
| Minority Interest | ¥-2M | ¥-3M | ¥-7M | ¥-1M | — |
| Comprehensive Income | ¥671M | ¥920M | ¥128M | ¥630M | ¥779M |
| EBITDA | ¥1.1B | ¥1.2B | ¥1.4B | ¥1.2B | ¥1.2B |
| Goodwill Amort. (J-GAAP) | ¥45M | ¥28M | ¥14M | ¥22M | ¥14M |
| EPS | ¥249.79 | ¥227.96 | ¥85.83 | ¥272.67 | ¥265.77 |
| Shares Outstanding | 2.5M | 2.5M | 2.6M | 2.6M | 2.6M |
| Shares Issued (total) | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M |
| Treasury Shares | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M |